Angiex, Inc. – Trademark Portfolio
Entity Type: 03
Angiex, Inc. holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 8 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include ANGIEX, NUCLEAR DELIVERY PLATFORM, and NUCLEAR-DELIVERED ANTIBODY-DRUG CONJUGATES. The owner is based in Cambridge, MA.
393 Broadway, #15
Cambridge, MA 02139
Showing of trademarks Trademarks
Trademark Classifications
Angiex, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Angiex, Inc. have?
Angiex, Inc. has 8 U.S. trademarks filed with the USPTO. Of these, 4 registered, 3 abandoned, 1 cancelled.
What trademark classes does Angiex, Inc. file in?
Angiex, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 5 (Pharmaceuticals). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Angiex, Inc.'s most well-known trademarks?
Angiex, Inc.'s registered trademark portfolio includes well-known marks such as ANGIEX, NUCLEAR DELIVERY PLATFORM, and NUCLEAR-DELIVERED ANTIBODY-DRUG CONJUGATES. These are among 4 currently registered trademarks in the portfolio.
What is Angiex, Inc.'s trademark registration success rate?
Angiex, Inc. has a 50% trademark registration rate, with 4 out of 8 resolved applications resulting in successful registration. Currently, 0 applications are pending review.